Transplantation: Are Calcineurin Inhibitors Safer Than mTOR Inhibitors?

Nature Reviews Nephrology- United Kingdom

doi 10.1038/nrneph.2012.262

Full Text

Abstract

Available in

Categories

Date

November 27, 2012

Authors

James F. Markmann

Publisher

Springer Science and Business Media LLC

Related search

Conversion From Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplantation: A Single Centre Experience

Turkish Nephrology, Dialysis and Transplantation Journal

English

Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors

American Journal of Transplantation

Transplantation

English

Are Calcineurin Inhibitors-Free Regimens Ready for Prime Time?

Kidney International

English

New Perspectives on mTOR Inhibitors (Rapamycin, Rapalogs and TORKinibs) in Transplantation

British Journal of Clinical Pharmacology

English

Comparison of Calcineurin Inhibitors With M-Tor Inhibitors in Renal Transplant Patients

Akdeniz Medical Journal

English

Calcineurin Inhibitors: 40 Years Later, Can't Live Without ...

Journal of Immunology

English

Impact of Calcineurin Inhibitors on Rat Glioma Cells Viability

Yeungnam University Journal of Medicine

English

The Use of Topical Calcineurin Inhibitors in Atopic Dermatitis

Open Dermatology Journal

English

Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics

Journal of Clinical Investigation

English